Immatics (IMTX) Net Cash Flow (2019 - 2025)
Immatics (IMTX) reported Net Cash Flow of $13.9 million for Q4 2025, down 67.8% on a YoY basis from $43.3 million in Q4 2024, and down 84.57% sequentially from $90.3 million in Q3 2025.
Immatics (IMTX) Net Cash Flow (2019 - 2025) Analysis & Trends
Immatics (IMTX) has 7 years of Net Cash Flow data on file, last reported at $13.9 million in Q4 2025.
- For the quarter ending Q4 2025, Net Cash Flow fell 67.8% year-over-year to $13.9 million; the trailing twelve-month figure through Dec 2025 stood at $144.4 million (up 1437.13% YoY), and the FY2025 full-year result was $141.8 million, up 1313.83% from the prior year.
- Net Cash Flow fell to $13.9 million in Q4 2025, from $90.3 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $148.3 million in Q4 2023 to a low of -$108.4 million in Q1 2024.
- A 5-year average of $7.1 million and a median of $11.5 million in 2022 frame the typical range for Net Cash Flow.
- Across the five-year window, Net Cash Flow plunged 1905.08% in 2022 and jumped 999.38% in 2023, its largest moves.
- Tracing IMTX's Net Cash Flow over 5 years: stood at -$31.7 million in 2021, then soared by 47.92% to -$16.5 million in 2022, then soared by 999.38% to $148.3 million in 2023, then tumbled by 70.84% to $43.3 million in 2024, then tumbled by 67.8% to $13.9 million in 2025.
- Business Quant data shows IMTX's Net Cash Flow at $13.9 million in Q4 2025, $90.3 million in Q3 2025, and $27.7 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Immatics | 1.14 Bn | 1.14 Bn | - | 13.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.93 Mn |
| Dec 31, 2025 | 13.93 Mn |
| Sep 30, 2025 | 90.27 Mn |
| Sep 30, 2025 | 90.27 Mn |
| Jun 30, 2025 | 27.69 Mn |
| Jun 30, 2025 | 27.69 Mn |
| Mar 31, 2025 | 12.48 Mn |
| Mar 31, 2025 | 12.48 Mn |
| Dec 31, 2024 | 43.25 Mn |
| Dec 31, 2024 | 43.25 Mn |
| Sep 30, 2024 | 35.73 Mn |
| Sep 30, 2024 | 35.73 Mn |
| Jun 30, 2024 | 38.81 Mn |
| Jun 30, 2024 | 38.81 Mn |
| Mar 31, 2024 | -108.40 Mn |
| Mar 31, 2024 | -108.40 Mn |
| Dec 31, 2023 | 148.31 Mn |
| Dec 31, 2023 | 148.31 Mn |
| Sep 30, 2023 | -55.73 Mn |
| Sep 30, 2023 | -55.73 Mn |